Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study

ABSTRACT:

SUBMITTER: Thompson W 

PROVIDER: S-EPMC12336545 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature